Iovance Biotherapeutics Inc (IOVA)

$2.85 -0.02 (-0.70%)
Market Cap 1.14B
Revenue (ttm) 164.07M
Net Income (ttm) -372.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.84%
Debt to Equity Ratio 0.00
Volume 8,113,400
Avg Vol 15,247,068
Day's Range N/A - N/A
Shares Out 396.97M
Stochastic %K 85%
Beta 0.83
Analysts Sell
Price Target $8.35

Company Profile

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanom...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 260 7120
Address:
825 Industrial Road, Suite 100, San Carlos, United States
Kaerasori
Kaerasori Dec. 27 at 6:28 PM
$IOVA shhhhh stop pumping. The sub-3 prices should be reserved only for the long time investors.
1 · Reply
MS1974
MS1974 Dec. 27 at 4:31 PM
$IOVA Just IOVA.
0 · Reply
Gius_me
Gius_me Dec. 27 at 4:29 PM
$IOVA 2026 must to be our turnaround. Share price goal: 10. We have q1 with at least 2 catalysts: one between endo or 4001 that can pump the price + 2025 final results and 2026 guidelines at min 300 mln + margin. If they won’t screw up margin and revenue, we should pop around 5 around mid year. Second half 2026 should be all related to lung for the final pop at 10.
2 · Reply
JohnEss
JohnEss Dec. 27 at 4:14 PM
$IOVA https://www.marketscreener.com/quote/stock/IOVANCE-BIOTHERAPEUTICS-I-36879287/consensus/
0 · Reply
The_Scientist
The_Scientist Dec. 27 at 2:46 PM
$IOVA for a moment yesterday there was a Christmas miracle, I was break even on this stock lol Happy holidays to the family here🎊 🎄 🎁 ☃️
0 · Reply
wenmoon_stonks
wenmoon_stonks Dec. 27 at 12:54 PM
$IOVA I'll State the obvious. Days like yesterday had to happen, it's part of the flow. A lot of other stuff was miserable most of the session and we were just kind of hanging in there. I consider that a positive. I remember buying this thing like everyone else here when everyone hated it, knowing the story was good and the patents were good. You got a long way to go, but the new leadership has a track record. It was a first of its kind approve treatment with other indications on the way. I have a feeling how patience will pay off.
0 · Reply
JohnEss
JohnEss Dec. 27 at 11:12 AM
$IOVA https://ascopubs.org/doi/10.1200/JCO-25-00765
3 · Reply
JohnEss
JohnEss Dec. 27 at 11:09 AM
$IOVA https://www.curemelanoma.org/patient-eng/melanoma-treatment/options/lifileucel-amtagvi
0 · Reply
Kai_01
Kai_01 Dec. 27 at 10:09 AM
$IOVA My mother has just opened her first investment account, at 63, and taken a small position in Iovance. I’m so excited!
5 · Reply
locallab
locallab Dec. 27 at 2:54 AM
$IOVA one day it will trend due to rapid gains. I just know it. Til then, buy more and stay diversified.
1 · Reply
Latest News on IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Dec 19, 2025, 5:15 PM EST - 7 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics: Base-Case Q3 Report Keeps 'Show Me' Mode

Nov 11, 2025, 1:24 PM EST - 6 weeks ago

Iovance Biotherapeutics: Base-Case Q3 Report Keeps 'Show Me' Mode

Iovance Biotherapeutics, Inc. (IOVA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:16 PM EST - 7 weeks ago

Iovance Biotherapeutics, Inc. (IOVA) Q3 2025 Earnings Call Transcript

IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders

Oct 29, 2025, 8:15 AM EDT - 2 months ago

IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders

Iovance: Q3 Earnings May Smart, But Long Term Bull Thesis Remains In Play

Oct 10, 2025, 10:30 AM EDT - 2 months ago

Iovance: Q3 Earnings May Smart, But Long Term Bull Thesis Remains In Play

Iovance Biotherapeutics to Present at Upcoming Conferences

Aug 29, 2025, 8:30 AM EDT - 4 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

Iovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25

Aug 21, 2025, 4:56 PM EDT - 4 months ago

Iovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25

Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

Aug 18, 2025, 4:15 PM EDT - 4 months ago

Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

Iovance Biotherapeutics, Inc. (IOVA) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:15 AM EDT - 5 months ago

Iovance Biotherapeutics, Inc. (IOVA) Q2 2025 Earnings Call Transcript

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

Aug 7, 2025, 4:01 PM EDT - 5 months ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

Here's why Iova stock surged 32% today and why the rally might not be over

Jul 23, 2025, 12:08 PM EDT - 5 months ago

Here's why Iova stock surged 32% today and why the rally might not be over

Iovance: I'm Switching From Sell To Buy Despite Likely Approval For Rival Drug

Jul 18, 2025, 12:02 PM EDT - 5 months ago

Iovance: I'm Switching From Sell To Buy Despite Likely Approval For Rival Drug

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 5 months ago

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

Jul 14, 2025, 9:04 AM EDT - 5 months ago

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

Jul 14, 2025, 7:30 AM EDT - 5 months ago

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 11, 2025, 10:32 AM EDT - 6 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

Jul 10, 2025, 4:01 PM EDT - 6 months ago

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

Jul 10, 2025, 8:18 AM EDT - 6 months ago

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 3, 2025, 7:35 AM EDT - 6 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure– Hagens Berman

Jul 2, 2025, 5:46 PM EDT - 6 months ago

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure– Hagens Berman

IOVA INVESTOR DEADLINE: Iovance Biotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 28, 2025, 7:46 AM EDT - 6 months ago

IOVA INVESTOR DEADLINE: Iovance Biotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit – IOVA

Jun 26, 2025, 4:45 PM EDT - 6 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit – IOVA

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA

Jun 26, 2025, 9:00 AM EDT - 6 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 24, 2025, 12:03 PM EDT - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

IOVA COURT REMINDER: Iovance Biotherapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 20, 2025, 9:07 AM EDT - 6 months ago

IOVA COURT REMINDER: Iovance Biotherapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure – Hagens Berman

Jun 18, 2025, 2:34 PM EDT - 6 months ago

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure – Hagens Berman

IOVA NOTICE: Did Iovance Biotherapeutics, Inc. Mislead Investors? Contact BFA Law by July 14 Court Deadline if You Suffered Losses (NASDAQ:IOVA)

Jun 18, 2025, 8:38 AM EDT - 6 months ago

IOVA NOTICE: Did Iovance Biotherapeutics, Inc. Mislead Investors? Contact BFA Law by July 14 Court Deadline if You Suffered Losses (NASDAQ:IOVA)

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 16, 2025, 8:17 AM EDT - 6 months ago

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, Inc. Stock Plummeted 44%? Contact BFA Law by the July 14 Court Deadline (NASDAQ:IOVA)

Jun 10, 2025, 8:47 AM EDT - 7 months ago

IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, Inc. Stock Plummeted 44%? Contact BFA Law by the July 14 Court Deadline (NASDAQ:IOVA)

Kaerasori
Kaerasori Dec. 27 at 6:28 PM
$IOVA shhhhh stop pumping. The sub-3 prices should be reserved only for the long time investors.
1 · Reply
MS1974
MS1974 Dec. 27 at 4:31 PM
$IOVA Just IOVA.
0 · Reply
Gius_me
Gius_me Dec. 27 at 4:29 PM
$IOVA 2026 must to be our turnaround. Share price goal: 10. We have q1 with at least 2 catalysts: one between endo or 4001 that can pump the price + 2025 final results and 2026 guidelines at min 300 mln + margin. If they won’t screw up margin and revenue, we should pop around 5 around mid year. Second half 2026 should be all related to lung for the final pop at 10.
2 · Reply
JohnEss
JohnEss Dec. 27 at 4:14 PM
$IOVA https://www.marketscreener.com/quote/stock/IOVANCE-BIOTHERAPEUTICS-I-36879287/consensus/
0 · Reply
The_Scientist
The_Scientist Dec. 27 at 2:46 PM
$IOVA for a moment yesterday there was a Christmas miracle, I was break even on this stock lol Happy holidays to the family here🎊 🎄 🎁 ☃️
0 · Reply
wenmoon_stonks
wenmoon_stonks Dec. 27 at 12:54 PM
$IOVA I'll State the obvious. Days like yesterday had to happen, it's part of the flow. A lot of other stuff was miserable most of the session and we were just kind of hanging in there. I consider that a positive. I remember buying this thing like everyone else here when everyone hated it, knowing the story was good and the patents were good. You got a long way to go, but the new leadership has a track record. It was a first of its kind approve treatment with other indications on the way. I have a feeling how patience will pay off.
0 · Reply
JohnEss
JohnEss Dec. 27 at 11:12 AM
$IOVA https://ascopubs.org/doi/10.1200/JCO-25-00765
3 · Reply
JohnEss
JohnEss Dec. 27 at 11:09 AM
$IOVA https://www.curemelanoma.org/patient-eng/melanoma-treatment/options/lifileucel-amtagvi
0 · Reply
Kai_01
Kai_01 Dec. 27 at 10:09 AM
$IOVA My mother has just opened her first investment account, at 63, and taken a small position in Iovance. I’m so excited!
5 · Reply
locallab
locallab Dec. 27 at 2:54 AM
$IOVA one day it will trend due to rapid gains. I just know it. Til then, buy more and stay diversified.
1 · Reply
beachsidefreddy
beachsidefreddy Dec. 26 at 11:55 PM
$IOVA
0 · Reply
dogbone98
dogbone98 Dec. 26 at 11:54 PM
$IOVA For this stock to only be down 2 cents on a low volume day with its huge SI is pretty damn good. So badly need to push well over $3 and finally start clawing back out of penny stock status.
4 · Reply
profits7
profits7 Dec. 26 at 11:38 PM
$IOVA Overall a great week! as we head towards the end of the year into what is sure to be a great 2026 for the company and it’s investors! 💵 💰 have a great weekend all!
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 26 at 9:46 PM
🔎 $IOVA Options Scan Update (15:46 CT) No standout unusual options activity right now. Bias: Neutral • Waiting for stronger flow https://smartoptions.ai
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 26 at 9:35 PM
$IOVA Current Stock Price: $2.85 Contracts to trade: $5 IOVA Dec 26 2025 Call Entry: $0.04 Exit: $0.05 ROI: 39% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DegenerateGambler546
DegenerateGambler546 Dec. 26 at 8:54 PM
$IOVA Possible bull flag formation?
1 · Reply
StormHunter89
StormHunter89 Dec. 26 at 8:14 PM
$IOVA Do we have a theory how many outstanding shares we will have end of 26? Makes it easier to calculate the price if a BO is on the table 😄thx in advance
4 · Reply
SnapCrackleStop
SnapCrackleStop Dec. 26 at 8:07 PM
$IOVA Price Action is not bad. I expect most positions are fixed to ‘26 Buckled up. Ready to ride in 2026 $
0 · Reply
Chi_Booth
Chi_Booth Dec. 26 at 7:45 PM
$IOVA Very low volume trading across the board as traders are on holidays. Today's price action means nothing.
0 · Reply
doggz109
doggz109 Dec. 26 at 7:02 PM
$IOVA Added a few hundred more shares today. Lets go!!!
0 · Reply
Hankcat
Hankcat Dec. 26 at 6:54 PM
$IOVA It would not surprise me if some of Big Pharma has already made overtures to IOVA. However, IOVA knows what the data for Lung data is. If it were mediocre, they would make a deal If it is as good as many on this board believe it to be, then they will wait to release it and then, and only then, we they be open to a buy-out. Only at that time the base will be multiple orders higher. And if 4Q shows they are increasing volume, and increasing margins and can show landing to profitability...then Katie Bar The Door(doesn't anybody say that anymore?) Finally, I sleep well holding this. after 2 years wandering the desert, 2026 will be our year.
1 · Reply
beachsidefreddy
beachsidefreddy Dec. 26 at 6:09 PM
$IOVA here come the bids I expected this pm
0 · Reply